PPT Slide
This presentation contains projections, estimates and other forward-looking statements that involve a number of risks and uncertainties, including those discussed in the Company’s filings with the Securities and Exchange Commission. These risks include, but are not limited to, delay or unfavorable results from current and future clinical trials, inability to commercially manufacture our drug candidates on a cost-effective basis, failure of Roche to meet its contractual obligations to us, inability to raise additional capital, and failure of our drug candidates to achieve market acceptance. While this presentation represents management’s current judgment on the future direction of the Company’s business, such risks and uncertainties could cause actual results to differ materially from any future performance suggested herein. The Company undertakes no obligation to update these forward-looking statements to reflect events or circumstances arising after the date hereof.